Показати скорочений опис матеріалу
dc.contributor.author | Chernyshova, K. | en |
dc.contributor.author | Yakimenko, O. | en |
dc.contributor.author | Bondar, V. | en |
dc.contributor.author | Chernyshova, H. | en |
dc.contributor.author | Kolomiets, S. | en |
dc.contributor.author | Oliynyk, D. | en |
dc.contributor.author | Tbileli, V. | en |
dc.contributor.author | Maznichenko, I. E. | en |
dc.date.accessioned | 2023-04-13T11:53:31Z | |
dc.date.available | 2023-04-13T11:53:31Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Additional opportunities for antihypertensive therapy improvement in young patients with arterial hypertension and concomitant obesity / K. Chernyshova, O. Yakimenko, V. Bondar et al // ESC Congress, 26–29 August 2022, Barcelona, Spain. 2022. P. 2195. | en |
dc.identifier.uri | https://repo.odmu.edu.ua:443/xmlui/handle/123456789/12507 | |
dc.description.abstract | The high prevalence of arterial hypertension (AH) and concomitant obesity in young patients is not only a medical but also a social problem. It is important to develop additional modern approaches to the management of young patients with AH and obesity, which will increase the effectiveness of existing antihypertensive (anti-AH) medical therapy and prevent early damage of target organs and complications. The purpose of the research was to evaluate the antihypertensive efficacy of the proposed complex treatment and its impact on quality of life in young patients with AH and obesity (or overweight). | en |
dc.language.iso | en | en |
dc.subject | antihypertensive therapy | en |
dc.subject | young patients | en |
dc.subject | arterial hypertension | en |
dc.subject | obesity | en |
dc.title | Additional opportunities for antihypertensive therapy improvement in young patients with arterial hypertension and concomitant obesity | en |
dc.type | Article | en |